title: Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
abstract: Amplified in breast cancer 1 (AIB1) (also known as steroid receptor coactivator-3) is a nuclear receptor coactivator enhancing estrogen receptor (ER)α and progesterone receptor (PR)-dependent transcription in breast cancer. The splice variant AIB1Δ3 demonstrates increased ability to promote ERα and PR-dependent transcription. Both are implicated in breast cancer risk and antihormone resistance. Conditional transgenic mice tested the in vivo impact of AIB1Δ3 overexpression compared with AIB1 on histological features of increased breast cancer risk and growth response to estrogen and progesterone in the mammary gland. Combining expression of either AIB1 or AIB1Δ3 with ERα overexpression, we investigated in vivo cooperativity. AIB1 and AIB1Δ3 overexpression equivalently increased the prevalence of hyperplastic alveolar nodules but not ductal hyperplasia or collagen content. When AIB1 or AIB1Δ3 overexpression was combined with ERα, both stromal collagen content and ductal hyperplasia prevalence were significantly increased and adenocarcinomas appeared. Overexpression of AIB1Δ3, especially combined with overexpressed ERα, led to an abnormal response to estrogen and progesterone with significant increases in stromal collagen content and development of a multilayered mammary epithelium. AIB1Δ3 overexpression was associated with a significant increase in PR expression and PR downstream signaling genes. AIB1 overexpression produced less marked growth abnormalities and no significant change in PR expression. In summary, AIB1Δ3 overexpression was more potent than AIB1 overexpression in increasing stromal collagen content, inducing abnormal mammary epithelial growth, altering PR expression levels, and mediating the response to estrogen and progesterone. Combining ERα overexpression with either AIB1 or AIB1Δ3 overexpression augmented abnormal growth responses in both epithelial and stromal compartments.
authors.affiliation: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
authors.forename: Rebecca E
authors.initials: RE
authors.lastname: Nakles
authors.forename: Maddalena Tilli
authors.initials: MT
authors.lastname: Shiffert
authors.forename: Edgar S
authors.initials: ES
authors.lastname: Díaz-Cruz
authors.forename: M Carla
authors.initials: MC
authors.lastname: Cabrera
authors.forename: Maram
authors.initials: M
authors.lastname: Alotaiby
authors.forename: Anne M
authors.initials: AM
authors.lastname: Miermont
authors.forename: Anna T
authors.initials: AT
authors.lastname: Riegel
authors.forename: Priscilla A
authors.initials: PA
authors.lastname: Furth
mesh_terms: D000230:Adenocarcinoma; D000818:Animals; D015153:Blotting, Western; D001943:Breast Neoplasms; D049109:Cell Proliferation; D003094:Collagen / Q000096:biosynthesis / Q000235:genetics; D004847:Epithelial Cells / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism*; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006965:Hyperplasia / Q000235:genetics / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D056921:Nuclear Receptor Coactivator 3 / Q000096:biosynthesis* / Q000235:genetics; D016133:Polymerase Chain Reaction; D011374:Progesterone / Q000378:metabolism; D020033:Protein Isoforms / Q000235:genetics; D011980:Receptors, Progesterone / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D017154:Stromal Cells / Q000378:metabolism*
chemical_list: D047628:Estrogen Receptor alpha; D004967:Estrogens; D020033:Protein Isoforms; D011980:Receptors, Progesterone; D011374:Progesterone; D003094:Collagen; C538867:Ncoa3 protein, mouse; D056921:Nuclear Receptor Coactivator 3